Paradoxical aging in HIV

Immune senescence of B Cells is most prominent in young age

Stefano Rinaldi, Suresh Pallikkuth, Varghese K. George, Lesley R. de Armas, Rajendra Pahwa, Celeste M. Sanchez, Maria Fernanda Pallin, Li Pan, Nicola Cotugno, Gordon Dickinson, Allan Rodriguez, Margaret Fischl, Maria Alcaide, Louis Gonzalez, Paolo Palma, Savita Pahwa

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Combination antiretroviral therapies (cART) can lead to normal life expectancy in HIV-infected persons, and people aged > 50 yrs represent the fastest growing HIV group. Although HIV and aging are independently associated with impaired humoral immunity, immune status in people aging with HIV is relatively unexplored. In this study influenza vaccination was used to probe age associated perturbations in the B cell compartment of HIV-negative "healthy controls" (HC) and virologically controlled HIV-infected participants on cART (HIV) (n=124), grouped by age as young (< 40 yrs), middle-aged (40-59yrs) or old (≥ 60 yrs). H1N1 antibody response at d21 post-vaccination correlated inversely with age in both HC and HIV. Immunophenotyping of cryopreserved PBMC demonstrated increased frequencies of double negative B cells and decreased plasmablasts in old compared to young HC. Remarkably, young HIV were different from young HC but similar to old HC in B cell phenotype, influenza specific spontaneous (d7) or memory (d21) antibody secreting cells. We conclude that B cell immune senescence is a prominent phenomenon in young HIV in comparison to young HC, but distinctions between old HIV and old HC are less evident though both groups manifest age-associated B cell dysfunction.

Original languageEnglish
Pages (from-to)1307-1325
Number of pages19
JournalAging
Volume9
Issue number4
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

B-Lymphocytes
HIV
Human Influenza
Vaccination
Antibody-Producing Cells
Immunophenotyping
Cell Aging
Humoral Immunity
Life Expectancy
Antibody Formation
Age Groups
Phenotype
Therapeutics

Keywords

  • Aging
  • B cells
  • Chronic infections
  • HIV
  • Immunosenescence
  • Influenza vaccination
  • PD1

ASJC Scopus subject areas

  • Ageing
  • Cell Biology

Cite this

Rinaldi, S., Pallikkuth, S., George, V. K., de Armas, L. R., Pahwa, R., Sanchez, C. M., ... Pahwa, S. (2017). Paradoxical aging in HIV: Immune senescence of B Cells is most prominent in young age. Aging, 9(4), 1307-1325. https://doi.org/10.18632/aging.101229

Paradoxical aging in HIV : Immune senescence of B Cells is most prominent in young age. / Rinaldi, Stefano; Pallikkuth, Suresh; George, Varghese K.; de Armas, Lesley R.; Pahwa, Rajendra; Sanchez, Celeste M.; Pallin, Maria Fernanda; Pan, Li; Cotugno, Nicola; Dickinson, Gordon; Rodriguez, Allan; Fischl, Margaret; Alcaide, Maria; Gonzalez, Louis; Palma, Paolo; Pahwa, Savita.

In: Aging, Vol. 9, No. 4, 01.01.2017, p. 1307-1325.

Research output: Contribution to journalArticle

Rinaldi, S, Pallikkuth, S, George, VK, de Armas, LR, Pahwa, R, Sanchez, CM, Pallin, MF, Pan, L, Cotugno, N, Dickinson, G, Rodriguez, A, Fischl, M, Alcaide, M, Gonzalez, L, Palma, P & Pahwa, S 2017, 'Paradoxical aging in HIV: Immune senescence of B Cells is most prominent in young age', Aging, vol. 9, no. 4, pp. 1307-1325. https://doi.org/10.18632/aging.101229
Rinaldi S, Pallikkuth S, George VK, de Armas LR, Pahwa R, Sanchez CM et al. Paradoxical aging in HIV: Immune senescence of B Cells is most prominent in young age. Aging. 2017 Jan 1;9(4):1307-1325. https://doi.org/10.18632/aging.101229
Rinaldi, Stefano ; Pallikkuth, Suresh ; George, Varghese K. ; de Armas, Lesley R. ; Pahwa, Rajendra ; Sanchez, Celeste M. ; Pallin, Maria Fernanda ; Pan, Li ; Cotugno, Nicola ; Dickinson, Gordon ; Rodriguez, Allan ; Fischl, Margaret ; Alcaide, Maria ; Gonzalez, Louis ; Palma, Paolo ; Pahwa, Savita. / Paradoxical aging in HIV : Immune senescence of B Cells is most prominent in young age. In: Aging. 2017 ; Vol. 9, No. 4. pp. 1307-1325.
@article{62c4d00e62534b9a8b2aca19b250c6f9,
title = "Paradoxical aging in HIV: Immune senescence of B Cells is most prominent in young age",
abstract = "Combination antiretroviral therapies (cART) can lead to normal life expectancy in HIV-infected persons, and people aged > 50 yrs represent the fastest growing HIV group. Although HIV and aging are independently associated with impaired humoral immunity, immune status in people aging with HIV is relatively unexplored. In this study influenza vaccination was used to probe age associated perturbations in the B cell compartment of HIV-negative {"}healthy controls{"} (HC) and virologically controlled HIV-infected participants on cART (HIV) (n=124), grouped by age as young (< 40 yrs), middle-aged (40-59yrs) or old (≥ 60 yrs). H1N1 antibody response at d21 post-vaccination correlated inversely with age in both HC and HIV. Immunophenotyping of cryopreserved PBMC demonstrated increased frequencies of double negative B cells and decreased plasmablasts in old compared to young HC. Remarkably, young HIV were different from young HC but similar to old HC in B cell phenotype, influenza specific spontaneous (d7) or memory (d21) antibody secreting cells. We conclude that B cell immune senescence is a prominent phenomenon in young HIV in comparison to young HC, but distinctions between old HIV and old HC are less evident though both groups manifest age-associated B cell dysfunction.",
keywords = "Aging, B cells, Chronic infections, HIV, Immunosenescence, Influenza vaccination, PD1",
author = "Stefano Rinaldi and Suresh Pallikkuth and George, {Varghese K.} and {de Armas}, {Lesley R.} and Rajendra Pahwa and Sanchez, {Celeste M.} and Pallin, {Maria Fernanda} and Li Pan and Nicola Cotugno and Gordon Dickinson and Allan Rodriguez and Margaret Fischl and Maria Alcaide and Louis Gonzalez and Paolo Palma and Savita Pahwa",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/aging.101229",
language = "English",
volume = "9",
pages = "1307--1325",
journal = "Aging",
issn = "1945-4589",
publisher = "US Administration on Aging",
number = "4",

}

TY - JOUR

T1 - Paradoxical aging in HIV

T2 - Immune senescence of B Cells is most prominent in young age

AU - Rinaldi, Stefano

AU - Pallikkuth, Suresh

AU - George, Varghese K.

AU - de Armas, Lesley R.

AU - Pahwa, Rajendra

AU - Sanchez, Celeste M.

AU - Pallin, Maria Fernanda

AU - Pan, Li

AU - Cotugno, Nicola

AU - Dickinson, Gordon

AU - Rodriguez, Allan

AU - Fischl, Margaret

AU - Alcaide, Maria

AU - Gonzalez, Louis

AU - Palma, Paolo

AU - Pahwa, Savita

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Combination antiretroviral therapies (cART) can lead to normal life expectancy in HIV-infected persons, and people aged > 50 yrs represent the fastest growing HIV group. Although HIV and aging are independently associated with impaired humoral immunity, immune status in people aging with HIV is relatively unexplored. In this study influenza vaccination was used to probe age associated perturbations in the B cell compartment of HIV-negative "healthy controls" (HC) and virologically controlled HIV-infected participants on cART (HIV) (n=124), grouped by age as young (< 40 yrs), middle-aged (40-59yrs) or old (≥ 60 yrs). H1N1 antibody response at d21 post-vaccination correlated inversely with age in both HC and HIV. Immunophenotyping of cryopreserved PBMC demonstrated increased frequencies of double negative B cells and decreased plasmablasts in old compared to young HC. Remarkably, young HIV were different from young HC but similar to old HC in B cell phenotype, influenza specific spontaneous (d7) or memory (d21) antibody secreting cells. We conclude that B cell immune senescence is a prominent phenomenon in young HIV in comparison to young HC, but distinctions between old HIV and old HC are less evident though both groups manifest age-associated B cell dysfunction.

AB - Combination antiretroviral therapies (cART) can lead to normal life expectancy in HIV-infected persons, and people aged > 50 yrs represent the fastest growing HIV group. Although HIV and aging are independently associated with impaired humoral immunity, immune status in people aging with HIV is relatively unexplored. In this study influenza vaccination was used to probe age associated perturbations in the B cell compartment of HIV-negative "healthy controls" (HC) and virologically controlled HIV-infected participants on cART (HIV) (n=124), grouped by age as young (< 40 yrs), middle-aged (40-59yrs) or old (≥ 60 yrs). H1N1 antibody response at d21 post-vaccination correlated inversely with age in both HC and HIV. Immunophenotyping of cryopreserved PBMC demonstrated increased frequencies of double negative B cells and decreased plasmablasts in old compared to young HC. Remarkably, young HIV were different from young HC but similar to old HC in B cell phenotype, influenza specific spontaneous (d7) or memory (d21) antibody secreting cells. We conclude that B cell immune senescence is a prominent phenomenon in young HIV in comparison to young HC, but distinctions between old HIV and old HC are less evident though both groups manifest age-associated B cell dysfunction.

KW - Aging

KW - B cells

KW - Chronic infections

KW - HIV

KW - Immunosenescence

KW - Influenza vaccination

KW - PD1

UR - http://www.scopus.com/inward/record.url?scp=85018993736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018993736&partnerID=8YFLogxK

U2 - 10.18632/aging.101229

DO - 10.18632/aging.101229

M3 - Article

VL - 9

SP - 1307

EP - 1325

JO - Aging

JF - Aging

SN - 1945-4589

IS - 4

ER -